These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 310574)

  • 1. Factors affecting the development of penicillamine side-effects.
    Corke CF; Huskisson EC
    Rheumatol Rehabil; 1978 Feb; 17(1):34-7. PubMed ID: 310574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Penicillamine treatment of rheumatoid arthritis: relationship of proteinuria and autoantibodies to immune status.
    Zilko PJ; Dawkins RL; Cohen ML
    Proc R Soc Med; 1977; 70 Suppl 3(Suppl 3):118-22. PubMed ID: 122657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Ro(SSA) positive rheumatoid arthritis (RA): a clinicoserological group of patients with high incidence of D-penicillamine side effects.
    Moutsopoulos HM; Skopouli FN; Sarras AK; Tsampoulas C; Mavridis AK; Constantopoulos SH; Maddison PJ
    Ann Rheum Dis; 1985 Apr; 44(4):215-9. PubMed ID: 3872635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [D-penicillamine induced lupus during the treatment of rheumatoid arthritis. Report of 2 cases and systematic immunologic study during the treatment].
    Crouzet J; Camus JP; Leca AP; Guillien P; Lièvre JA
    Ann Med Interne (Paris); 1974 Jan; 125(1):71-9. PubMed ID: 4136184
    [No Abstract]   [Full Text] [Related]  

  • 5. The side effects of penicillamine therapy in rheumatoid arthritis.
    Huskisson EC
    J Rheumatol Suppl; 1981; 7():146-8. PubMed ID: 6939876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Penicillamine in rheumatoid disease: a long-term study.
    Day AT; Golding JR; Lee PN; Butterworth AD
    Br Med J; 1974 Feb; 1(5900):180-3. PubMed ID: 4590670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteinuria in D-penicillamine-treated rheumatoid arthritis.
    Crawhall JC
    J Rheumatol Suppl; 1981; 7():161-3. PubMed ID: 6939879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Penicillin allergy in rheumatoid arthritis. With special reference to Sjogren's syndrome.
    Williams BO; St Onge RA; Young A; Nuki G; Dick WC; Whaley K
    Ann Rheum Dis; 1969 Nov; 28(6):607-11. PubMed ID: 5308134
    [No Abstract]   [Full Text] [Related]  

  • 9. [Are antinuclear factors a contraindication for penicillamine treatment in patients with rheumatoid arthritis? (author's transl)].
    Scherak O; Hiesberger H; Kolarz G
    Wien Klin Wochenschr; 1978 Feb; 90(3):95-6. PubMed ID: 304637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Penicillamine nephropathy in rheumatoid arthritis. A clinical, pathological and immunological study.
    Bacon PA; Tribe CR; Mackenzie JC; Verrier-Jones J; Cumming RH; Amer B
    Q J Med; 1976 Oct; 45(180):661-84. PubMed ID: 1005658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple side effects of penicillamine therapy in one patient with rheumatoid arthritis.
    Essigman WK
    Ann Rheum Dis; 1982 Dec; 41(6):617-20. PubMed ID: 6216862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of proteinuria secondary to penicillamine therapy in rheumatoid arthritis.
    DeSilva RN; Eastmond CJ
    Clin Rheumatol; 1992 Jun; 11(2):216-9. PubMed ID: 1617896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between D-penicillamine--induced proteinuria and prior gold nephropathy.
    Billingsley LM; Stevens MB
    Johns Hopkins Med J; 1981 Feb; 148(2):64-7. PubMed ID: 7206401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Polymyositis induced by D-penicillamine treatment of rheumatoid arthritis: apropos of 2 cases with antinuclear antibodies].
    Masson CJ; Ménard HA; Audran M; Renier JC; Lussier A; Myhal DM
    Union Med Can; 1986 Dec; 115(12):855-9. PubMed ID: 3492802
    [No Abstract]   [Full Text] [Related]  

  • 15. D-penicillamine toxicity in Greek patients with rheumatoid arthritis: anti-Ro(SSA) antibodies and cryoglobulinemia are predictive factors.
    Vlachoyiannopoulos PG; Zerva LV; Skopouli FN; Drosos AA; Moutsopoulos HM
    J Rheumatol; 1991 Jan; 18(1):44-9. PubMed ID: 1827158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Progress on diagnosis and therapy of kidney diseases complicated with rheumatoid arthritis and Sjogren's syndrome].
    Dohi K; Morita H
    Nihon Naika Gakkai Zasshi; 1992 Jan; 81(1):22-7. PubMed ID: 1556457
    [No Abstract]   [Full Text] [Related]  

  • 17. The development of membranous glomerulonephritis in a patient with rheumatoid arthritis and Sjögren's syndrome.
    Schwartzberg M; Burnstein SL; Calabro JJ; Jacobs JB
    J Rheumatol; 1979; 6(1):65-70. PubMed ID: 439113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic markers in rheumatoid arthritis relationship to toxicity from D-penicillamine.
    Stockman A; Zilko PJ; Major GA; Tait BD; Property DN; Mathews JD; Hannah MC; McCluskey J; Muirden KD
    J Rheumatol; 1986 Apr; 13(2):269-73. PubMed ID: 3459889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of previous gold toxicity on subsequent development of penicillamine toxicity.
    Smith PJ; Swinburn WR; Swinson DR; Stewart IM
    Br Med J (Clin Res Ed); 1982 Aug 28-Sep 4; 285(6342):595-6. PubMed ID: 6218857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Among the antinuclear antibodies in rheumatoid polyarthritis: antihistone antibodies detected by an immunoenzymatic technic].
    Le Goff P; Muller S; Lelong A; Jouquan J; Youinou P
    Rev Rhum Mal Osteoartic; 1988 Nov; 55(11):919-22. PubMed ID: 3264618
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.